Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iodine pentoxide |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodine pentafluoride |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodine trichloride |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodine heptafluoride |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodine monobromide |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodine monochloride |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodine compounds adverse reaction |
Causative agent |
True |
Iodine compound |
Inferred relationship |
Some |
1 |
Iodine adverse reaction |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
|
Iodophore adverse reaction |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
|
Povidone iodine adverse reaction |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
|
iodidakne |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
2 |
Cadexomer iodine (substance) |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Allergy to iodine compound (finding) |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
|
Allergy to iodophore (finding) |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
|
Allergy to povidone iodine |
Causative agent |
False |
Iodine compound |
Inferred relationship |
Some |
|
Iodophore (substance) |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
iodprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Aqueous iodine 130mg/mL oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iodforbindelser |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Iodine weak solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Iodine strong solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Potassium iodide 65 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Potassium iodide 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Product containing iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
kaliumjodid 130 mg + teofyllin 80 mg vandfri eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + jod 370 mg/ml injektionsvæske, opløsning, flaske á 125 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Product containing potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, flaske a 300 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 180 mg + iod 85 mg/ml (18 %) injektionsvæske, opløsning, flaske a 300 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 2000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + jod 370 mg/ml injektionsvæske, opløsning, hætteglas á 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
natriumiodid 118 µg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
natriumiodid 100 µg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 175 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Ethanol- and iodine- and potassium iodide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine compound |
Inferred relationship |
Some |
|
Allergy to iodine compound (finding) |
Causative agent |
True |
Iodine compound |
Inferred relationship |
Some |
1 |
Iodine supplement (substance) |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Sodium iodine (substance) |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Sodium iodohippurate (substance) |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Dithiazanine iodide |
Is a |
False |
Iodine compound |
Inferred relationship |
Some |
|
Periodate salt |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodinated contrast media (substance) |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodide salt |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodinated glycerol |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Chloriodised oil |
Is a |
False |
Iodine compound |
Inferred relationship |
Some |
|
jodatsalt |
Is a |
False |
Iodine compound |
Inferred relationship |
Some |
|
Iodine compounds overdose |
Causative agent |
True |
Iodine compound |
Inferred relationship |
Some |
1 |
Protein-bound iodine |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodoform |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Iodic acid |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Ioxaglic acid |
Is a |
False |
Iodine compound |
Inferred relationship |
Some |
|
Ioxynil |
Is a |
True |
Iodine compound |
Inferred relationship |
Some |
|
Acneiform eruption due to iodine compound |
Causative agent |
True |
Iodine compound |
Inferred relationship |
Some |
1 |
Iodine acne |
Causative agent |
True |
Iodine compound |
Inferred relationship |
Some |
1 |